Found 11 matching trials
Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
PHASE2The purpose of this study is to define the response and toxicities with the...
Location
National Cancer Center Singapore
Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
PHASE3The aim of the study is to improve the loco-regional control rate and overa...
Location
Flinders Medical Centre
Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN
PHASE2Radiotherapy alone is generally the only treatment in old patients with SCC...
Location
Multiple Locations
Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma
PHASE3This is a phase III randomized clinical trial of definitive radiotherapy pl...
Status
Active Not Recruiting
Location
Sun Yat-sen Universitty Cancer Center
Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
PHASE2This study aimed to investigate the clinical benefit contribution and safet...
Location
Sun Yat-sen University Cancer Center
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
PHASE2The purpose of this study is to evaluate the efficiency and safety of addin...
Location
Gansu Province Medical Science Institute
Nimotuzumab in Adults With Glioblastoma Multiforma
PHASE3Determination of efficiency of nimotuzumab in adults with glioblastoma mult...
Location
Dep. Neurosurgery, Univ. Hamburg
Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses
PHASE2Prospective, non-blinded, randomised two cohorts study on the efficacy of t...
Location
Fondazione IRCCS Istituto Nazionale Tumori
Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer
PHASE2This Phase II randomized study is to determine the efficacy and toxicity of...
Location
Sun yat-sen University Cancer Center
A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma
PHASE3Esophageal cancer is the sixth leading cause of cancer death in worldwide. ...
Location
Cancer Hospital Chinese Academy of Medical Sciences